Scope of Correlogic's ovarian cancer test under FDA review
This article was originally published in Clinica
Executive Summary
The US FDA has requested a meeting with Correlogic Systems of Bethesda, Maryland, to discuss "the appropriate regulatory status" of the company's test for early stage ovarian cancer.